N4 Pharma PLC (LON:N4P) shares were up 2.5% on Wednesday . The stock traded as high as GBX 5.65 ($0.07) and last traded at GBX 5.64 ($0.07), approximately 945,187 shares changed hands during mid-day trading. A decline of 46% from the average daily volume of 1,760,000 shares. The stock had previously closed at GBX 5.50 ($0.07).
The company has a fifty day moving average price of GBX 4.89. The company has a current ratio of 5.63, a quick ratio of 5.57 and a debt-to-equity ratio of 4.09. The stock has a market capitalization of $5.43 million and a price-to-earnings ratio of -4.12.
N4 Pharma Company Profile (LON:N4P)
N4 Pharma Plc, a specialist pharmaceutical company, develops and licenses novel therapeutic products pharmaceutical and biotechnology companies in the United Kingdom. It reformulates marketed generic drugs; and improves delivery of novel and existing vaccines and therapeutics. The company is developing Sildenafil for use in treating erectile dysfunction; Sartans for the treatment of hypertension; Aprepitant for use in oncology and pain relief; and Aprepitant for the treatment of premature ejaculation.
Featured Story: Capital gains and your 401(k) or IRA
Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.com's FREE daily email newsletter.